LucianMiron(Cismarescu)ManuMD
Psychiatry • Stony Brook, NYPsychopharmacology
Clinical Assistant Professor, Psychiatry & Behavioral Science, Stony Brook Univ SOM
Dr. Manu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Stony Brook University School of Medicine
101 Nicolls Road, HSC T-10
Stony Brook, NY 11794Phone+1 631-632-2428Fax+1 631-632-5870
Summary
- Dr. Lucian Manu is a psychiatrist in Stony Brook, NY. He received his medical degree from Carol Davila University of Medicine and Pharmacy and has been in practice 25 years. He also speaks multiple languages, including Romanian. He specializes in neuromodulation, interventional psychiatry, psychopharmacology and integrative psychiatry and is experienced in depression, mood disorders, major depression, treatment resistant depression, anxiety disorders, transcranial magnetic stimulation, ketamine intra nasal therapy, ketamine intra venous therapy, ketamine-assisted psychotherapy, vagal nerve stimulation therapy, psychedelic therapies.
Education & Training
NYU Grossman School of MedicineResidency, Psychiatry, 1993 - 1997
Carol Davila University of Medicine and PharmacyClass of 1990
Certifications & Licensure
NY State Medical License 1996 - 2025
NJ State Medical License 1997 - 1999- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide Start of enrollment: 2017 Jun 15
Publications & Presentations
PubMed
- 12 citationsDeep rTMS of the insula and prefrontal cortex in smokers with schizophrenia: Proof-of-concept study.Scott J Moeller, Roberto Gil, Jodi J Weinstein, Topaz Baumvoll, Kenneth Wengler
Schizophrenia. 2022-02-25 - Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis: Letter in ...Lucian Manu
Neuropsychiatric Disease and Treatment. 2023-01-01
Professional Memberships
- Clinical TMS SocietyMember
- American Society of Ketamine PhysiciansMember
Other Languages
- Romanian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
